Neoleukin Therapeutics (NLTX) Stock Chart & Stock Price History $22.34 +1.36 (+6.48%) As of 10/3/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock Neoleukin Therapeutics Stock Price Performance The Neoleukin Therapeutics (NLTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 54.02%, with a year-to-date return of -2.74%. In the past month, the stock has increased 13.92%, reflecting recent market activity. As of the latest close, Neoleukin Therapeutics traded at $20.98 with a market cap of $197.17 million and volume of 507,588 shares. Five years ago, the stock traded at a split-adjusted price of $249.40, representing a 91.04% decrease over that period. At the time, it had a market cap of $520.61 million and a volume of 5,703 shares. Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+28.91%1 Month Performance+13.92%3 Month Performance+13.11%Year-To-Date Performance-2.74%1 Year Performance-54.02%5 Year Performance-91.04% NLTX Stock Chart for Monday, October, 6, 2025 NLTX Chart by TradingView Neoleukin Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/06/2025$22.34$22.34$24.50$20.00466,574 shs$209.95 million10/03/2025$17.98$20.98+16.72%$21.41$17.76507,588 shs$197.17 million10/02/2025$17.33$17.98+3.72%$18.48$17.29101,096 shs$168.93 million10/01/2025$17.71$17.33-2.15%$18.06$17.18128,360 shs$162.87 million09/30/2025$17.82$17.71-0.62%$18.15$17.51138,324 shs$166.44 million09/29/2025$17.82$17.82$18.13$17.24117,549 shs$167.47 million09/26/2025$17.25$17.41+0.90%$17.45$16.85127,774 shs$163.57 million09/25/2025$16.85$17.25+2.37%$17.53$16.94128,315 shs$162.12 million09/24/2025$16.98$16.85-0.77%$17.51$16.77152,097 shs$158.36 million09/23/2025$17.20$16.98-1.28%$17.93$16.95221,381 shs$159.58 million Get the Latest News and Ratings for NLTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/22/2025$17.20$17.20$18.68$17.00215,471 shs$161.65 million09/19/2025$17.71$18.68+5.48%$18.94$17.64131,618 shs$175.56 million09/18/2025$17.44$17.71+1.55%$18.40$17.55111,407 shs$166.44 million09/17/2025$19.00$17.44-8.21%$18.30$17.13188,989 shs$163.90 million09/16/2025$19.00$19.00$20.42$18.77123,069 shs$178.56 million09/15/2025$19.00$19.00$20.42$18.77123,069 shs$178.56 million09/12/2025$18.60$20.08+7.96%$20.72$18.62829,800 shs$188.71 million09/11/2025$19.25$18.60-3.38%$19.63$18.3796,282 shs$174.80 million09/10/2025$19.45$19.25-1.03%$19.79$18.7355,926 shs$180.91 million09/09/2025$19.95$19.45-2.51%$20.01$18.84103,379 shs$182.79 million09/08/2025$19.95$19.95$20.67$19.58195,621 shs$187.49 million09/05/2025$19.87$19.61-1.31%$19.91$19.3056,852 shs$184.30 million Related Companies MBX Biosciences Stock Price Chart Nanobiotix Stock Price Chart Savara Stock Price Chart AnaptysBio Stock Price Chart Organogenesis Stock Price Chart Bicara Therapeutics Stock Price Chart Opthea Stock Price Chart Inventiva Stock Price Chart Olema Pharmaceuticals Stock Price Chart Arcturus Therapeutics Stock Price Chart Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NLTX) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIs This Warren’s Buffett’s #1 AI Investment?Did you know that Warren Buffett is investing in what Jeff Brown believes will be the next generation of artif...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neoleukin Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neoleukin Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
